Streetbeat News

Products Services

OST

Ostin Technology Group has secured orders for metro projects in Beijing, Tianjin, and Nanjing of China, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 12:37 pm

JNJ

Janssen, a pharmaceutical company of Johnson & Johnson (JNJ), announced positive topline results from its Phase 3 Papillon study. The study, which evaluated Rybrevant in combination with chemotherapy, met its primary endpoint.

Portfolio Pulse from Happy Mohamed

July 17, 2023 | 12:37 pm

AMZN

NTWK

NETSOL Cloud Services, a division of NETSOL Technologies, Inc. (NASDAQ:NTWK), has been awarded the AWS Lambda Service Delivery designation by Amazon Web Services (AWS). This recognition acknowledges NETSOL's expertise in implementing AWS Lambda, a platform that allows businesses to run code without managing servers, thereby improving agility, reducing infrastructure costs, and accelerating time-to-market for applications.

Portfolio Pulse from Happy Mohamed

July 17, 2023 | 12:36 pm

PRTA

Prothena Corporation has presented new research data from its PRX012, PRX005, and PRX123 programs at the Alzheimer's Association International Conference. The data showcases the potential of Prothena's pipeline and its commitment to transforming the care of patients with Alzheimer's disease.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 12:36 pm

MCOM

Helbiz, a company under micromobility.com Inc. (NASDAQ:MCOM), has been granted a three-year permit renewal to operate in Palermo, Sicily. The permit allows for the deployment of up to 1000 electric scooters, reinforcing Helbiz's role in promoting sustainable transport in the region. The company was awarded the top spot in a competitive application process.

Portfolio Pulse from Happy Mohamed

July 17, 2023 | 12:33 pm

OST

Ostin Technology Group (NASDAQ:OST), a Chinese supplier of display modules and polarizers, has secured orders for metro projects in Beijing, Tianjin, and Nanjing. The company will supply platform door displays, metro Passenger Information System screens, and metro platform monitors. These products are designed to enhance the commuting experience and accommodate security needs. The company's display modules are tailored to provide high performance and contribute to the efficiency and safety of the metro systems.

Portfolio Pulse from Happy Mohamed

July 17, 2023 | 12:33 pm

SPCE

Virgin Galactic Holdings Inc (NYSE:SPCE) has announced the crew of its seventh spaceflight and second commercial spaceflight, 'Galactic 02.' The flight will carry three private passengers to space, including the first astronauts from the Caribbean, the first mother-daughter duo, and the first Olympian. The company's shares are trading higher by 1.32% at $3.85 in premarket on the last check Monday.

Portfolio Pulse from Shivani Kumaresan

July 17, 2023 | 12:32 pm

BBIO

PFE

BridgeBio Pharma Inc (BBIO) announced positive results from its ATTRibute-CM Phase 3 study of acoramidis in transthyretin amyloid cardiomyopathy. The study showed significant improvement in the primary endpoint and a survival rate of 81% versus placebo survival rate of 74%. The company also observed a 50% relative risk reduction in cardiovascular-related hospitalization. In comparison to Pfizer Inc's (PFE) Vyndaqel/Vyndamax, acoramidis showed a 42% greater increase in serum TTR levels and a 92% improvement in median NT-proBNP. BBIO plans to file a New Drug Application with the FDA by the end of 2023. BBIO shares are up 59.30% in premarket trading.

Portfolio Pulse from Vandana Singh

July 17, 2023 | 12:31 pm

META

A developer has used AI to translate and lip-sync a YouTube interview between Lex Fridman and Meta Platforms Inc CEO Mark Zuckerberg from English to Hindi. The developer, Prady, used AI tools including ChatGPT, voice training, and speech-to-text tools from 11labs, and a lip synchronization API. This highlights the accessibility of audio and video editing due to AI, but also raises concerns about the potential misuse of these tools to spread misinformation.

Portfolio Pulse from Rounak Jain

July 17, 2023 | 12:30 pm

ARGX

ZLAB

Argenx SE reported positive results from the ADHERE study evaluating Vyvgart Hytrulo in adults with chronic inflammatory demyelinating polyneuropathy (CIDP). The study met its primary endpoint with a 61% reduction in the risk of relapse versus placebo with up to 48 weeks of treatment. Argenx has an exclusive license agreement with Zai Lab Limited for developing and commercializing Vyvgart and Vyvgart Hytrulo in Greater China. Following the news, ARGX shares are up 27.10% and ZLAB stock is up 7.72% in the premarket session.

Portfolio Pulse from Vandana Singh

July 17, 2023 | 12:25 pm